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Abstract
Nuclear hormone receptors (NHRs) are transcription factors that regulate carbohydrate and lipid metabolism, immune
responses, and inflammation. Although several NHRs, including peroxisome proliferator-activated receptor-c (PPARc) and
PPARa, demonstrate a renoprotective effect in the context of diabetic nephropathy (DN), the expression and role of other
NHRs in the kidney are still unrecognized. To investigate potential roles of NHRs in the biology of the kidney, we used
quantitative real-time polymerase chain reaction to profile the expression of all 49 members of the mouse NHR superfamily
in mouse kidney tissue (C57BL/6 and db/m), and cell lines of mesangial (MES13), podocyte (MPC), proximal tubular epithelial
(mProx24) and collecting duct (mIMCD3) origins in both normal and high-glucose conditions. In C57BL/6 mouse kidney
cells, hepatocyte nuclear factor 4a, chicken ovalbumin upstream promoter transcription factor II (COUP-TFII) and COUP-TFIII
were highly expressed. During hyperglycemia, the expression of the NHR 4A subgroup including neuron-derived clone 77
(Nur77), nuclear receptor-related factor 1, and neuron-derived orphan receptor 1 significantly increased in diabetic C57BL/6
and db/db mice. In renal cell lines, PPARd was highly expressed in mesangial and proximal tubular epithelial cells, while
COUP-TFs were highly expressed in podocytes, proximal tubular epithelial cells, and collecting duct cells. High-glucose
conditions increased the expression of Nur77 in mesangial and collecting duct cells, and liver x receptor a in podocytes.
These data demonstrate NHR expression in mouse kidney cells and cultured renal cell lines and suggest potential
therapeutic targets in the kidney for the treatment of DN.
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Introduction
Diabetic nephropathy (DN) is a major microvascular compli-
cation in patients with diabetes mellitus, ultimately leading to end-
stage renal diseases [1]. The incidence of DN is increasing rapidly
with the increase in patients with type 2 diabetes and metabolic
syndrome, and at present accounts for almost 50% of all end-stage
renal diseases [2]. It is characterized by the accumulation of
extracellular matrix in the glomerular and tubulointerstitial
compartments and by the thickening and hyalinization of
intrarenal vasculature. Various pathogenic mechanisms of DN
have been proposed including increased expression of advanced
glycation end-products, protein kinase C, transforming growth
factor b, and reactive oxygen species. In addition to these
metabolic derangements, changes in the glomerular hemodynam-
ics, modulated in part by local activation of the renin-angiotensin
system, synergistically exacerbate the progression of DN. Despite
notable advances in the treatment of diabetes mellitus, current
therapies do not fully suppress the incidence of DN. Therefore,
identification of additional causative factors leading to renal injury
and the development of novel agents to prevent or treat DN are
urgently needed.
In humans, 48 members of the nuclear hormone receptor
(NHR) superfamily of transcription factors have been identified (49
in mice). Several modulators of NHRs have been developed as oral
drugs for the treatment of diabetes and dyslipidemia. Synthetic
agonists for peroxisome proliferator-activated receptor-c (PPARc)
and PPARa, such as thiazolidinediones and fibrates, improve
glycemic control in type 2 diabetic patients and lower serum
triglyceride levels in hyperlipidemic patients [3]. Moreover, these
drugs are reported to have protective effects against renal
dysfunction [4,5,6]. However, no drugs that modulate NHRs,
other than PPARc and PPARa agonists, have been released in the
market. In animal models of DN, several agonists of NHRs,
including the vitamin D receptor (VDR) [7,8], the farnesoid X
receptor (FXR) [9], and the estrogen receptor (ER) [10] have been
reported to have potential suppressive effects on the progression of
DN. We have also demonstrated that synthetic agonists of PPARd
[11] and the liver X receptor (LXR) [12] reduce urinary albumin
excretion in a mouse model of DN. Moreover, hepatocyte nuclear
factor a (HNF4a) [13] and estrogen-related receptor (ERR) [14]
are also thought to have a role in the pathogenesis of DN.
There is increasing evidence of NHR expression in peripheral
tissues including adipose tissue [15], macrophages [16], and
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endocrine pancreas tissue [17], but little is known about the
expression and function of NHRs in the kidney. To elucidate their
potential role in the pathogenesis of DN, we have performed a
comprehensive analysis of NHR expression in mouse kidney tissue
and renal cell lines.
Materials and Methods
Animals
Eight-week-old male C57BL/6J mice were purchased from
Charles River (Yokohama, Japan). Diabetes was induced by
peritoneal injection of 200 mg/kg streptozotocin (Sigma-Aldrich,
Tokyo, Japan) in citrate buffer (pH 4.5). C57BL/6J mice were
euthanized at 8 weeks after the induction of diabetes. Six-week-old
male diabetic db/db mice (BKS.Cg-leprdb/leprdb) and male non-
diabetic db/m mice (BKS.Cg-leprdb/+) were purchased from CLEA
Japan (Tokyo, Japan). Db/db mice and db/m mice were euthanized
at 9 weeks of age. All mice were maintained under a 12-h light/12-
h dark cycle with free access to food and tap water. Animal care
and procedures were performed according to the Guidelines for
Animal Experimentation at Okayama University, the Japanese
Government Animal Protection and Management Law, and the
Japanese Government Notification on Feeding and Safekeeping of
Animals. The experimental protocol was approved by the Animal
Ethics Review Committee of Okayama University (OKU-
2011326). All surgery was performed under sodium pentobarbital
anesthesia, and every effort was made to minimize suffering.
Cell culture
Murine mesangial (MES13), podocyte (MPC), proximal tubular
epithelial (mProx24), and collecting duct (mIMCD3) cells were
cultured as previously described [18,19,20]. For high-glucose
stimulation, renal cell lines were serum-starved in 0.5% fetal
bovine serum for 24 h. Subsequently, all cells were exposed to low-
glucose (5.5 mM) or high-glucose (25 mM) conditions for 24 h
before RNA isolation.
RNA measurement
RNA was isolated from kidney cortex samples or cultured cells
using an RNeasy Mini kit (Qiagen, Valencia, CA, USA). Single-
strand cDNA was synthesized from the extracted RNA using a
real-time polymerase chain reaction (RT-PCR) kit (Perkin Elmer,
Foster City, CA, USA). To evaluate the mRNA expression of each
NHR, quantitative RT-PCR (qPCR) was performed using
TaqManH Array Plates and StepOnePlusTM (Applied Biosystems,
Foster City, CA, USA) and TaqManH Fast Universal PCR Master
Mix (Applied Biosystems). Primers were purchased from Applied
Biosystems. Each sample was analyzed in quadruplicate and
normalized for S18 mRNA expression. Primer sequences for
mouse genes are provided in Table S1.
Immunohistochemistry
Immunofluorescent staining was performed as described previ-
ously [21]. The expression of VDR in cultured renal cells was
detected using rat anti-VDR antibody (Abcam, Cambridge, UK)
followed by Alexa Fluor 488 goat anti-rat IgG (Invitrogen,
Carlsbad, CA). Similarly, PPARd and COUP-TFII were detected
using rabbit anti-PPARd (Affinity Bioreagents, Golden, CO) and
anti-COUP-TFII antibody (Abcam) followed by Alexa Fluor 488
goat anti-rabbit IgG (Invitrogen). Renal expression of NOR1 was
detected using mouse anti-NOR1 antibody (Abcam) followed by
Alexa Fluor 488 goat anti-mouse IgG (Invitrogen). To determine
whether NOR1 was localized in mesangial cells, podocytes,
proximal tubular epithelial cells, or collecting duct cells, the
sections were counter-stained with rabbit anti-fibronectin antibody
(Sigma-Aldrich, St. Louis, MO), rabbit anti-WT-1 antibody
(Abcam, Cambridge, UK), rabbit anti-aquaporin 1 (AQP1)
antibody (Millipore, Temecula, CA), or rabbit anti-AQP2
antibody (Abcam) respectively, followed by Alexa Fluor 594 goat
anti-rabbit IgG (Invitrogen). Fluorescence images were obtained
using a fluorescence microscope (BX51; Olympus, Tokyo, Japan).
Results
The expression of NHRs in mouse kidney tissue (C57/BL6 and
db/m) and renal (mesangial, podocyte, proximal tubular epithelial,
and collecting duct) cell lines was determined by qPCR analysis.
The composition and rank order of NHR expression in C57/
BL6 mouse kidney are shown in Figures 1 and 2A, respectively.
We then analyzed NHR expression in db/m mice and renal cell
lines (Figs. 2B–F, 3, 4, and 5). This format is consistent with
previous NHR expression analyses and provides a basis for
comparison with cell lines commonly associated with each
receptor type. Furthermore, because this survey focused on
expression in a select few cell types (mouse kidney, renal cell
lines), we could analyze RNA levels for all receptors in a single
assay for direct comparison of NHR levels within a given tissue.
Finally, we elucidated the effect of elevated glucose on NHR
expression in mouse kidney and renal cell lines (Fig. 6, 7, 8, and 9).
NHR expression in kidney
The composition of NHR expression in C57/BL6 mouse kidney
is shown in Figure 1. Receptors were deemed to be expressed if
cycle threshold (Ct) values were less than 31. Composite gene
expression analysis of the NHR superfamily revealed the presence
of 25 of the 49 known NHRs in C57BL/6 mouse kidney. These
included six members of the endocrine receptor family, which are
activated by high-affinity hormonal lipids, eight adopted hetero-
dimeric orphan receptors, which are regulated by low-affinity
dietary lipids, and 11 true orphan receptors (Fig. 1A). Figure 1B
shows a complete tabulation of the expressed and unexpressed
receptors along with their classification and nomenclature [22].
Six NHRs including FXRb, liver receptor homolog-1 (LRH1),
photoreceptor cell-specific nuclear receptor (PNR), retinoid X
receptor c (RXRc), steroidogenic factor 1 (SF1), and Tailles
homolog orphan receptor (TLX) were not detected in normal
C57BL/6 mouse kidney.
Rank order of NHR expression in mouse kidney tissue
and renal cell lines
The relative mRNA levels of NHRs expressed in C57BL/6
mouse kidney are shown in rank order in Figure 2A. For the
purposes of comparison, similar analyses were conducted on db/m
mouse kidney and renal cell lines (mesangial cell, MES13;
podocytes, MPC; proximal tubular epithelial, mProx24, and
collecting duct, mIMCD3) (Fig. 2B–F).
In C57BL/6 mouse kidney, the most abundant receptor was
HNF4a and other abundant receptors were chicken ovalbumin
upstream promoter transcription factor II (COUP-TFII) and
COUP-TFIII, VDR, PPARa, FXRb, and ERRa. In contrast,
COUP-TFII was the most abundant NHR in db/m mouse
kidney, and the mRNA levels of HNF4a, COUP-TFIII, and VDR
were lower in db/m mice than in C57BL/6 mice.
A similar survey of NHR transcripts in renal cell lines revealed
significant differences compared with the receptor expression
pattern observed in mouse kidney. COUP-TFII was the most
abundant NHR in the mProx24 and mIMCD3 cell lines, and the
second most abundant receptor in the MPC cell line. In contrast,
Nuclear Hormone Receptors in Kidney
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PPARd was the most highly expressed receptor in the MES13 cell
line, and the second most abundant NHR in the mProx24 cell line.
In addition to PPARd, thyroid hormone receptor a (TRa),
COUP-TFII, COUP-TFIII, glucocorticoid receptor (GR), RXRa,
and LXRb were found to be abundant receptors in the MES13
cell line. In the MPC cell line, COUP-TFII, COUP-TFIII,
RXRa, LXRb, TRa, and GR were highly expressed, while
COUP-TFII, PPARd, COUP-TFIII, and TRa were abundant in
the mProx24 cell line. In the mIMCD3 cell line, the expression
pattern of NHRs was similar to that in the MPC cell line.
Furthermore, retinoic acid receptor a (RARa), reverse-ErbAb
(Rev-ERBb), and PPARd were highly expressed NHRs in the
mIMCD3 cell line.
Endocrine receptors in renal cell lines
The expression of endocrine receptors was compared for all
renal cell lines (Fig. 3A). Androgen receptor (AR), RARa, and
VDR were highly expressed NHRs in the mProx24 cell line. In
contrast, AR and VDR were hardly expressed in the MPC and
mIMCD3 cell lines. ERa, GR, and TRa were abundant in both
the mProx24 and MES13 cell lines. Immunohistochemistry of
VDR showed that the intensity of VDR was higher in the
mProx24 cell line than in the MES13 cell line (Fig. 3B).
Adopted orphan receptor expression in renal cell lines
The expression of adopted orphan receptors in the renal cell
lines was also compared (Fig. 4A). LXRa and PPARa were highly
expressed in the MES13 cell line, while LXRb and PPARd were
Figure 1. Composition of nuclear hormone receptors (NHRs) in the kidney of C57BL/6 mice. (A) Twenty-five of 49 known NHRs are
expressed in C57BL/6 mouse kidney. These include six endocrine receptors that bind hormonal lipids with high-affinity, eight adopted orphan
receptors that bind dietary lipids with low-affinity, and 11 orphan receptors. Constituent receptors of each of these classes are listed. (B) Tabular
listing of NHRs expressed or unexpressed in C57BL/6 mouse kidney along with their classification and nomenclature. Receptors were deemed
unexpressed if cycle threshold (Ct) values exceeded 31.
doi:10.1371/journal.pone.0085594.g001
Nuclear Hormone Receptors in Kidney
PLOS ONE | www.plosone.org 3 January 2014 | Volume 9 | Issue 1 | e85594
Figure 2. Comparative expression levels of 49 nuclear hormone receptors (NHRs) in mouse kidney tissue and renal cell lines. The
relative mRNA levels are depicted for mouse kidney (C57BL/6 (A) and db/m (B)) and mesangial (MES13) (C), podocyte (MPC) (D), proximal tubular
epithelial (mProx24) (E) and collecting duct (mIMCD3) (F) cell lines. All values are expressed relative to 18S and arithmetically adjusted to depict the
highest-expressed NHR for each tissue/cell line as a unit of 100. Values represent the means 6 SEM of three independent samples of each tissue or
cell line. Setting arbitrary cutoffs at Ct,31 (present) or Ct.31 (absent), as shown by broken lines in the C57BL/6 mouse kidney panel, reveals that 25
NHRs were expressed and six NHRs were not detected in C57BL/6 mouse kidney.
doi:10.1371/journal.pone.0085594.g002
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highly expressed in both the MES13 and mProx24 cell lines.
FXRa, RXRa, and RXRb were predominantly expressed in the
mProx24 cell line. In contrast, adopted orphan receptors were
expressed at low levels in the MPC and mIMCD3 cell lines.
Immunofluorescent staining showed that PPARd was expressed in
both the MES13 and mProx24 cell lines (Fig. 4B).
Orphan receptor expression in renal cell lines
We also compared the expression of orphan receptors in the
renal cell lines (Fig. 5A). ERRa, HNF4a, retinoic acid-related
orphan receptor a (RORa), and RevERBb were highly expressed
in the MES13 cell line, while COUP-TFII and RORc were highly
expressed in the mProx24 cell line. COUP-TFIII, RevERBa, and
testicular orphan receptor 4 (TR4) were abundant in both the
mProx24 and MES13 cell lines. Intriguingly, high expression of
ERRa was detected in the MPC cell line, while ERRc
predominated in the mIMCD3 cell line. Immunohistochemistry
showed that COUP-TFII was expressed in both the MES13 and
mProx24 cell lines (Fig. 5B).
Figure 3. Endocrine receptors expressed in renal cell lines. (A) The relative mRNA levels are depicted for mesangial (MES13), podocyte (MPC),
proximal tubular epithelial (mProx24), and collecting duct (mIMCD3) cell lines. All values are expressed relative to 18S and arithmetically adjusted to
depict the lowest-expressing sample as a unit of 1. Values represent the means6 SEM of three independent samples of each cell lines, and the results
are representative of two independent studies. (B) Representative photomicrographs of immunofluorescent staining. Vitamin D receptor (VDR) was
predominantly expressed in mProx24 cells, and to a lesser extent in MES13 cells.
doi:10.1371/journal.pone.0085594.g003
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Glucose regulation of NHR expression in mouse kidney
tissue and renal cell lines
To determine differential expression of NHRs in response to
hyperglycemia, we compared the expression of NHRs in the
kidneys of streptozotocin-induced type 1 diabetic C57BL/6 mice
and control C57BL/6 mice (Fig. 6). Similarly, we compared NHR
expression in the kidneys of type 2 diabetic db/db mice and
control db/m mice (Fig. 6). Furthermore, we evaluated the
expression of the 49 NHRs in renal cell lines to determine whether
changes in RNA levels occur in high-glucose conditions (Fig. 7).
Renal cell lines were exposed to low-glucose (5.5 mM) or high-
glucose (25 mM) conditions for 24 h before RNA isolation.
Significantly increased RNA levels were observed for neuron-
derived orphan receptor 1 (NOR1) and nuclear receptor-related
factor 1 (NURR1), members of the NHR 4A (NR4A) subgroup,
and ERb and ERRb, members of the NR3A subgroup, in the
kidneys of streptozotocin-induced diabetic C57BL/6 mice (Fig. 6).
A similar increase in NURR1, NOR1, and ERb mRNA was
observed in the kidneys of diabetic db/db mice (Fig. 6).
Interestingly, neuron-derived clone 77 (Nur77), which is a member
of the NR4A subgroup, was also upregulated as well as NURR1
and NOR1 in db/db mouse kidney.
A similar evaluation of glucose-mediated changes in gene
expression in renal cell lines was performed (Fig. 7). In the MES13
cell line, upregulation of the expression of the NR4A members of
the NHR superfamily (Nur77.NOR1.NURR1), as well as that
of PPARc and PPARd was detected. The rank order of NHR
expression in the MPC cell line was LXRa, RARb, ERRb, FXRa,
ERa, TRb, RORb, LXRb. In the mProx24 cell line, RORa was
the most highly upregulated receptor while Nur77, NOR1,
PPARd, RevERBa, and PPARa were also upregulated in high-
Figure 4. Adopted orphan receptors expressed in renal cell lines. (A) Refer to the legend for Figure 3A for details. (B) Representative
photomicrographs of immunofluorescent staining. Peroxisome proliferator-activated receptor-d (PPARd) was expressed in both MES13 and mProx24
cell lines.
doi:10.1371/journal.pone.0085594.g004
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glucose conditions. Similar to the MES13 cell line, high-glucose
exposure increased the expression of the NR4A members
(Nur77.NURR1.NOR1) as well as RevERBb, RORa, PPARd,
and RevERBa in the mIMCD3 cell line.
Since the RNA level of NOR1 was the highest in the kidneys of
streptozotocin-induced diabetic C57BL/6 mice, and the third
highest in diabetic db/db mice (Fig. 6), we confirmed NOR1
expression by immunohistochemistry. The expression of NOR1 in
the glomeruli of diabetic C57BL/6 mice coexists with fibronectin,
a marker for mesangial cells, but not with WT-1, a marker for
podocytes (Fig. 8). On the other hand, NOR1 expression in the
interstitium of diabetic C57BL/6 mice coexists with both AQP1
and AQP2, markers for proximal tubular epithelial and collecting
duct cells, respectively (Fig. 8). These expressions are consistent
with those in qPCR (Fig. 7). Similarly, NOR1 expression was
detected in mesangial, proximal tubular epithelial, and collecting
Figure 5. Orphan receptors expressed in renal cell lines. (A) Refer to the legend for Figure 3A for details. (B) Representative photomicrographs
of immunofluorescent staining. Chicken ovalbumin upstream promoter transcription factor II (COUP-TFII) was expressed in both MES13 and mProx24
cell lines.
doi:10.1371/journal.pone.0085594.g005
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duct cells, but not in podocytes in the kidneys of diabetic db/db
mice (Fig. 9).
Discussion
NHRs are one of the largest transcription factor families in the
mammalian genome. A total of 48 human and 49 mouse genes
that encode NHRs have been identified [23]. Recently, the
quantitative assessment of NHR RNA levels has been established
for various mouse tissues including adipocytes [15], macrophages
[16], pancreas [17,24], retina [25], and during the circadian cycle
in mouse liver, adipose, and muscle [26] by using qPCR.
However, the expression of NHRs in the kidney remains
unknown. Therefore, we analyzed NHR expression in mouse
kidney tissue and renal cell lines.
In this study, we identified 25 NHRs that are expressed in
C57BL/6 mouse kidney. The receptors detected in abundance,
including HNF4a, VDR, PPARa, FXR, and ERRa, have already
been reported to play a role in the pathogenesis of DN [27].
However, we provide the first evidence that COUP-TFII and
COUP-TFIII are expressed abundantly in C57BL/6 mouse
kidney, with COUP-TFII being the most abundant NHR in the
kidneys of db/m mice. In the renal cell lines, COUP-TFII was
shown to be the most abundant NHR in proximal tubular
epithelial and collecting duct cells, and highly expressed in
mesangial cells and podocytes. Similarly, COUP-TFIII was shown
to be the most abundant NHR in podocytes, and highly expressed
in mesangial cells, proximal tubular epithelial cells, and podocytes.
COUP-TFII is thought to have a role in kidney development and
to be necessary for metanephric mesenchyme formation and
kidney precursor cell survival [28,29]. In contrast, the role of
COUP-TFII in DN is completely unknown and further studies are
required.
The analysis of NHR expression in renal cell lines showed that
most are expressed mainly in proximal tubular epithelial cells and
mesangial cells. However, we showed that PPARa and LXRa are
more highly expressed in mesangial cells than in the other renal
cell types, which is consistent with previous reports that PPARa
and LXRa are expressed in mesangial cells [30,31,32,33]. Since
synthetic agonists for PPARa and LXRa are reported to increase
cholesterol efflux and ameliorate lipid-related glomerular disease
[31,32,34], it can be speculated that these NHRs in mesangial cells
represent therapeutic targets for treating glomerular injuries in
DN. Moreover, the endocrine receptors, ERa, TRa, and VDR,
the adopted orphan receptors, PPARd, LXRb, and FXRa, and
the orphan receptors, COUP-TFII, COUP-TFIII, RORa,
RORc, RevERBa, and RevERBb, are expressed not only in
mesangial cells, but also in proximal tubular epithelial cells.
Furthermore, the expressions of endocrine receptor VDR, orphan
receptor PPARd, and adopted orphan receptor COUP-TFIII
were confirmed by immunohistochemistry (Figs. 3B, 4B, 5B).
RevERBs and RORs are thought to play important roles in the
regulation of circadian rhythm [26]; however, their functions in
the kidney remain to be fully elucidated. Our data suggest that
these receptors play fundamental roles in renal function.
ERRs are highly expressed in the kidney and renal cell lines.
Intriguingly, ERRa is the only NHR that is highly expressed in
podocytes, while ERRc is the only NHR that is highly expressed in
collecting duct cells. It is reported that ERRa is a key regulator of
interferon-c-induced mitochondrial reactive oxygen species pro-
duction and host defense [35], while both ERRa and ERRc
synergistically orchestrate a comprehensive cardiac transcriptional
program [36]. Regarding the kidney, ERRa and ERRc are
expressed in the outer stripe of the outer medulla of mouse kidney
[37], suggesting that these receptors regulate renal potassium
Figure 6. Comparative expression levels of NHRs in mouse kidney tissue under high-glucose conditions. The relative mRNA levels are
depicted for streptozotocin-induced diabetic C57BL/6 mouse kidney compared with control C57BL/6 mouse kidney (upper panel), and diabetic db/
db mouse kidney compared with control db/m mouse kidney (lower panel). Values depict the means 6 SEM of three independent samples.
doi:10.1371/journal.pone.0085594.g006
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homeostasis and the renin-angiotensin system [38,39]. Although
ERRa is induced by PPARc coactivator-1a (PGC-1a) [40], little is
known about the role and function of ERRa in podocytes and
further studies are needed.
The most interesting and novel finding in this study is that the
members of the NR4A subgroup, including NOR1, NURR1, and
Nur77, are highly induced in the kidneys of diabetic C57BL/6 and
db/db mice. All three members of the NR4A subgroup are
expressed in energy-dependent tissues such as skeletal muscle,
Figure 7. Comparative expression levels of NHRs in renal cell lines under high-glucose conditions. Mesangial (MES13), podocyte (MPC),
proximal tubular epithelial (mProx24), and collecting duct (mIMCD3) cell lines. Each panel displays NHR expression under high-glucose conditions
compared with low-glucose conditions. Values depict the means 6 SEM of three independent samples. HG, high-glucose. LG, low-glucose.
doi:10.1371/journal.pone.0085594.g007
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brain, adipose tissues, heart, and liver suggesting a possible role in
energy metabolism [41]. Although it is known that kidney
expression of the NR4A subgroup is upregulated by stimulation
of parathyroid hormone [42] or prostaglandin E2 [43], the effects
of high-glucose stimulation on the expression of these receptors
have not been reported. To confirm the results of qPCR, we
performed immunohistochemistry of NOR1 in the kidneys of
diabetic C57BL/6J and db/db mice. Double staining of NOR1
with markers for mesangial cells (fibronectin), podocytes (WT-1),
proximal tubular cells (AQP1), and collecting duct cells (AQP2)
revealed that NOR1 was expressed in mesangial cells, proximal
tubular cells, and collecting duct cells, but not in podocytes (Fig. 8
and 9). Our in vitro studies showed that NOR1, Nur77, and
NURR1 are also highly upregulated in cultured mesangial cells,
proximal tubular epithelial cells, and collecting duct cells. These
results might help to elucidate the previously unrecognized
mechanisms of the progression of DN. To the best of our
knowledge, there have been no studies investigating the expression
of NR4A subgroup in patients with DN, and further studies using
renal biopsy specimens are needed as the next step.
We were surprised that the expression profile of NHRs in the
kidneys of diabetic C57BL/6J and db/db mice is partially
overlapping like the members of the NR4A subgroup, but mostly
different as shown in Fig. 6. This difference may be caused by the
effect of streptozotocin injection in C57BL/6J mice or by deletion
of the leptin receptor gene in db/db mice. Another surprise was
that these NHRs were not differentially upregulated or even
downregulated in the kidneys of diabetic mice or high-glucose
treated renal cell lines. Several agonists of NHRs, including
PPARc, PPARa, VDR, and FXR have been reported to have
potential suppressive effects on the progression of DN [44]. Our
results are consistent with the reports of previous studies that the
expression of PPARa, VDR, and FXR was downregulated by the
induction of diabetes [33,45]. The precise mechanism for
downregulation of these NHRs in response to hyperglycemia is
unknown, but activation of these NHRs may prevent the
development of DN in mouse models. Based on these observa-
tions, we speculate that the inactivation of upregulated NHRs in
hyperglycemia, such as NOR1, NURR1, and Nur77, may also be
a potential therapeutic approach in the management of DN.
Further studies are required to address whether modulation of
these NHRs will provide a novel strategy for treating DN.
In summary, we have analyzed the expression of all NHRs
present in normal and high-glucose conditions in mouse kidney
tissue and renal cell lines. The functions of most of these NHRs are
still unknown; however, our data provide the basis for further
studies to elucidate potential therapeutic targets in the pathogen-
esis of DN.
Figure 8. Representative photomicrographs of double immunofluorescent staining in diabetic C57BL/6 mice. NOR1 expression was
localized in mesangial, proximal tubular epithelial, and collecting duct cells, but not in podocytes in the kidneys of diabetic C57BL/6 mice.
doi:10.1371/journal.pone.0085594.g008
Nuclear Hormone Receptors in Kidney
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